Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Drug Saf. 2006 May;5(3):401-16.

Safety and tolerability of mood-stabilising anticonvulsants in the elderly.

Author information

1
Menlo Park Division, Palo Alto Veterans Affairs Healthcare System, Menlo Park, California 94025, USA. howard.fenn@med.va.gov

Abstract

The authors review current research on the safety and tolerability of anticonvulsant medications used for individuals over the age of 60 years with affective disorders, agitation and other psychiatric disorders. Three anticonvulsants currently approved in the US for treatment of bipolar affective disorder are reviewed: valproate, lamotrigine and extended-release carbamazepine. The authors discuss the pharmacokinetics, pharmacodynamics, drug-drug interactions and the impact of ageing for each drug. There are few studies of anticonvulsant medications in elderly patients with bipolar disorder or other psychiatric conditions. Therefore, the authors summarise adverse events of greatest prevalence and/or greatest severity based on data derived predominately from studies of geriatric patients with epilepsy and/or other non-psychiatric indications. Guidelines are offered for the safe use of these medications in the elderly, based on research literature.

PMID:
16610969
DOI:
10.1517/14740338.5.3.401
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center